Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
書誌事項
- 公開日
- 2017-10
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.1016/s1473-3099(17)30496-6
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- The Lancet Infectious Diseases
-
The Lancet Infectious Diseases 17 (10), 1062-1068, 2017-10
Elsevier BV